Lancet Diabetes & Endocrinology, 2213-8587

Journal

Related Publications
  1. Urine metabolomic phenotyping for detection of adrenocortical carcinoma: Still a long way to go - Authors' reply

    ENSAT EURINE-ACT Investigators, Nov-2020, In : Lancet Diabetes & Endocrinology. 8, 11, p. 877-878 2 p.

    Research output: Contribution to journalLetterAcademic

  2. Effects of the SGLT2 inhibitor dapagliflozin on proteinuria in non-diabetic patients with chronic kidney disease (DIAMOND): a randomised, double-blind, crossover trial

    DIAMOND investigators, Cherney, D. Z. I., Dekkers, C. C. J., Barbour, S. J., Cattran, D., Abdul Gafor, A. H., Greasley, P. J., Laverman, G. D., Lim, S. K., Di Tanna, G. L., Reich, H. N., Vervloet, M. G., Wong, M. G., Gansevoort, R. T. & Heerspink, H. J. L., Jul-2020, In : Lancet Diabetes & Endocrinology. 8, 7, p. 582-593 12 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  3. Early detection of diabetic kidney disease by urinary proteomics and subsequent intervention with spironolactone to delay progression (PRIORITY): a prospective observational study and embedded randomised placebo-controlled trial

    PRIORITY Investigators, Tofte, N., Lindhardt, M., Adamova, K., Bakker, S. J. L., Beige, J., Beulens, J. W. J., Birkenfeld, A. L., Currie, G., Delles, C., Dimos, I., Francova, L., Frimodt-Moller, M., Girman, P., Goeke, R., Havrdova, T., Heerspink, H. J. L., Kooy, A., Laverman, G. D., Mischak, H., Navis, G., Nijpels, G., Noutsou, M., Ortiz, A., Parvanova, A., Persson, F., Petrie, J. R., Ruggenenti, P. L., Rutters, F., Rychlik, I., Siwy, J., Spasovski, G., Speeckaert, M., Trillini, M., Zuerbig, P., von der Leyen, H. & Rossing, P., Apr-2020, In : Lancet Diabetes & Endocrinology. 8, 4, p. 301-312 12 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  4. Urine steroid metabolomics for the differential diagnosis of adrenal incidentalomas in the EURINE-ACT study: A prospective test validation study

    ENSAT EURINE-ACT Investigators, Sep-2020, In : Lancet Diabetes & Endocrinology. 8, 9, p. 773-781 9 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  5. SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysis

    Neuen, B. L., Young, T., Heerspink, H. J. L., Neal, B., Perkovic, V., Billot, L., Mahaffey, K. W., Charytan, D. M., Wheeler, D. C., Arnott, C., Bornpoint, S., Levin, A. & Jardine, M. J., Nov-2019, In : Lancet Diabetes & Endocrinology. 7, 11, p. 845-854 10 p.

    Research output: Contribution to journalReview articleAcademicpeer-review

View all (43) »

ID: 13418602